BioCentury
ARTICLE | Company News

Laboratory Corp. of America Holdings, Mayo Foundation for Medical Education and Research sales and marketing update

February 20, 2006 8:00 AM UTC

LH launched a test to detect mutations in the UGT1A1 gene that are associated with serious adverse reactions in colorectal cancer patients receiving Camptosar irinotecan from Pfizer Inc. (PFE, New Y...